eMedicine Specialties > Emergency Medicine > Infectious Diseases

Prostatitis

Author: Tarlan Hedayati, MD, Instructor of Clinical Emergency Medicine, Director of Observation Unit, Director of Chest Pain Unit, Department of Emergency Medicine, Los Angeles County/University of Southern California Medical Center
Coauthor(s): Molly Keegan, MD, Resident Physician, Department of Emergency Medicine, Los Angeles County and USC Medical Center
Contributor Information and Disclosures

Updated: Jul 29, 2009

Introduction

Background

Prostatitis is an infection or inflammation of the prostate gland that presents as several syndromes with varying clinical features. The term prostatitis is defined as microscopic inflammation of the tissue of the prostate gland, which spans a broad range of clinical conditions.

The National Institutes of Health (NIH) has recognized and defined a classification system for prostatitis in 1999. The 4 syndromes of prostatitis are as follows: 

Acute and chronic bacterial prostatitis are defined by documented bacterial infections of the prostate. 

Chronic pelvic pain syndrome (CPPS) is characterized primarily by urological pain complaints in the absence of urinary tract infection. This syndrome includes several exclusion criteria, such as presence of active urethritis, urogenital cancer, urinary tract disease, functionally significant urethral stricture, or neurological disease affecting the bladder. It is subdivided into inflammatory and noninflammatory subtypes. Inflammatory CPPS is defined by the presence of white cells in the semen, expressed prostatic secretions, or voided bladder urine post-prostatic massage. Noninflammatory CPPS is defined by the absence of white cells.1

Asymptomatic inflammatory prostatitis is characterized by the incidental discovery of prostatic inflammation without any genitourinary complaints. These patients do not present to the emergency department but rather are diagnosed while undergoing workup for infertility or elevated prostate-specific antigen (PSA) level.

Pathophysiology

In bacterial prostatitis, sexual transmission of bacteria is common, but hematogenous, lymphatic, and contiguous spread of infection from surrounding anatomy must also be considered. Although various routes have been postulated, none have been firmly substantiated.

A history of sexually transmitted diseases is associated with an increased risk for prostatitis symptoms. Prostatitis symptoms may increase a man's risk for benign prostatic hyperplasia (BPH), lower urinary tract symptoms, and prostate cancer.2

The presence of acute inflammatory cells in the glandular epithelium and lumens of the prostate, with chronic inflammatory cells in the periglandular tissue, characterizes prostatitis. However, the presence and quantity of inflammatory cells in the urine or prostatic secretions does not correlate with the severity of physical symptoms.


A nonspecific mixed inflammatory infiltrate that ...

A nonspecific mixed inflammatory infiltrate that consists of lymphocytes, plasma cells, and histiocytes is typical in chronic bacterial prostatitis.

A nonspecific mixed inflammatory infiltrate that ...

A nonspecific mixed inflammatory infiltrate that consists of lymphocytes, plasma cells, and histiocytes is typical in chronic bacterial prostatitis.



Chronic pelvic pain syndrome is diagnosed based on pain in the setting of negative culture results of the urine and prostatic secretions. Neuromuscular dysfunction or congenital reflux of urine into the ejaculatory and prostatic ducts may be a precipitating factor.

Viral and granulomatous prostatitis may be associated with HIV infection and is another cause of culture-negative disease. A common viral pathogen of prostatitis in HIV-infected patients is cytomegalovirus (CMV). Mycobacteria, such as Mycobacterium tuberculosis, and fungi, such as Candida albicans, have also been associated with culture-negative disease in this population.

Frequency

United States

Prostatitis is one of the most common diseases seen in urology practices in the United States, accounting for nearly 2 million outpatient visits per year, with chronic bacterial prostatitis and chronic pelvic pain syndrome being most frequently diagnosed. The diagnosis of prostatitis is made in approximately 25% of male patients presenting with genitourinary symptoms. Autopsy studies have revealed a histologic prevalence of prostatitis of 64-86%.

Approximately 8.2% of men have prostatitis at some point in their lives.1  Of the 4 categories of prostatitis, the most common is chronic prostatitis/chronic pelvic pain syndrome, accounting for 90-95% of cases of prostatitis. Acute bacterial prostatitis and chronic bacterial prostatitis each make up another 2-5% of cases.

International

The incidence of mycobacterial prostatitis, concomitant with disseminated disease, is increased in underdeveloped countries. Areas with widespread sexually transmitted disease (STD) rates and prostitution have a higher incidence of acute bacterial prostatitis.

Mortality/Morbidity

  • Particularly susceptible patients include those with diabetes mellitus, patients on dialysis for chronic renal failure, patients who are immunocompromised, and postsurgical patients who have had urethral instrumentation. In these patients, prostatitis can lead to urosepsis with significant associated mortality. Do not overlook the prostate gland when searching for a source of sepsis in these patients.
  • In the United States, the long-term prognosis of the first occurrence of acute bacterial prostatitis is good with antibiotic therapy in compliant patients.

Sex

  • Prostatitis is a disease of men only.

Age

  • In patients younger than 35 years, the most common variant of the syndrome is acute bacterial prostatitis.
  • HIV-related disease is also predominantly seen in younger patients.
  • Rare causes should be noted. According to case reports of Wegener granulomatosis in the fourth and fifth decades of life, prostatitis can be a presenting feature of Wegener granulomatosis and a clinical manifestation of relapse. Fungal infection with C albicans and Coccidioides immitis and mycobacterial infection with M tuberculosis have also been reported.

Clinical

History

  • Acute bacterial prostatitis
    • Fever
    • Chills
    • Malaise
    • Arthralgias
    • Myalgias
    • Perineal prostatic pain
    • Dysuria
    • Obstructive urinary tract symptoms, including frequency, urgency, dysuria, nocturia, hesitancy, weak stream, and incomplete voiding
    • Low back pain
    • Low abdominal pain
    • Spontaneous urethral discharge
  • Chronic bacterial prostatitis
    • Intermittent dysuria
    • Intermittent obstructive urinary tract symptoms
    • Recurrent urinary tract infections1
    • Systemic symptoms typically absent 
  • Chronic prostatitis and chronic pelvic pain syndrome
    • Pelvic pain or discomfort including perineal, suprapubic, coccygeal, rectal, urethral, and testicular/scrotal pain for more than 3 of the previous 6 months without documented urinary tract infections from uropathogens.1
    • Obstructive urinary tract symptoms, including frequency, dysuria, and incomplete voiding
    • Ejaculatory pain
    • Erectile dysfunction
  • Asymptomatic inflammatory prostatitis - This diagnosis is defined by its lack of symptoms.

Physical

  • Acute bacterial prostatitis
    • Tender, nodular, hot, boggy, or normal-feeling gland on digital rectal examination
    • Suprapubic abdominal tenderness
    • Enlarged tender bladder due to urinary retention
  • Chronic bacterial prostatitis
    • Normal examination findings between acute episodes
    • Tender, nodular, or normal gland on digital rectal examination
    • Suprapubic tenderness during acute episodes
  • Chronic prostatitis and chronic pelvic pain syndrome
    • Mildly tender or normal prostate on digital rectal examination
    • Tight anal sphincter on digital rectal examination
  • Asymptomatic inflammatory prostatitis - Normal or calcified prostate on digital rectal examination

Causes

  • Consider Neisseria gonorrhoeae and Chlamydia trachomatis infection in any male younger than 35 years presenting with urinary tract symptoms.
  • Acute bacterial prostatitis may be caused by the following:
    • Ascending infection through the urethra
    • Refluxing urine into prostate ducts
    • Direct extension or lymphatic spread from the rectum
    • Approximately 80% are gram-negative organisms (eg, Escherichia coli, Enterobacter, Serratia, Pseudomonas, Enterococcus, and Proteus species). Mixed bacterial infections are uncommon. One case report of prostatitis caused by methicillin-resistant Staphylococcus aureus was documented in a diabetic patient.
  • Chronic bacterial prostatitis may be due to the following:
    • A primary voiding dysfunction, either structurally or functionally
    • E coli is responsible for 75-80% of chronic bacterial prostatitis cases. Enterococci and gram-negative aerobes such as Pseudomonas are usually isolated the remainder of the time.
    • C trachomatis, Ureaplasma species, Trichomonas vaginalis
    • Uncommon organisms, such as M tuberculosis and Coccidioides, Histoplasma, and Candida species , must also be considered. Tuberculous prostatitis may be found in patients with renal tuberculosis.
    • Human immunodeficiency virus
    • Cytomegalovirus
    • Inflammatory conditions such as sarcoidosis
  • Chronic prostatitis and chronic pelvic pain syndrome
    • About 5-8% of men with this syndrome eventually have a bacterial pathogen isolated from their urine or prostatic fluid.


Bacterial prostatitis. Expressed prostatic fluid ...

Bacterial prostatitis. Expressed prostatic fluid contains more than 10 white blood cells per high-power field, indicating prostatitis.

Bacterial prostatitis. Expressed prostatic fluid ...

Bacterial prostatitis. Expressed prostatic fluid contains more than 10 white blood cells per high-power field, indicating prostatitis.

    • Etiology is poorly understood but may result from an infectious or inflammatory initiator that results in neurologic injury and eventually results in pelvic floor dysfunction in the form of increased pelvic tone.1
    • Functional or structural bladder pathology, such as primary vesical neck obstruction, pseudodyssynergia (failure of the external sphincter to relax during voiding), impaired detrusor contractility, or acontractile detrusor muscle
    • Ejaculatory duct obstruction
    • Increased pelvic side wall tension
    • Nonspecific prostatic inflammation
  • Asymptomatic inflammatory prostatitis - Causes are similar to chronic inflammatory prostatitis without symptoms.

More on Prostatitis

Overview: Prostatitis
Differential Diagnoses & Workup: Prostatitis
Treatment & Medication: Prostatitis
Follow-up: Prostatitis
Multimedia: Prostatitis
References

References

  1. Murphy AB, Macejko A, Taylor A, Nadler RB. Chronic prostatitis: management strategies. Drugs. 2009;69(1):71-84. [Medline].

  2. Krieger JN, Lee SW, Jeon J, Cheah PY, Liong ML, Riley, et al. Epidemiology of Prostatitis. Int J Antimicrob Agents. Feb 2008;Suppl 1:85-90. [Medline].

  3. Loeb S, Gashti SN, Catalona WJ. Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA). Urol Oncol. Jan-Feb 2009;27(1):64-6. [Medline].

  4. [Guideline] Grabe M, Bishop MC, Bjerklund-Johansen TE, et al. Prostatitis and chronic pelvic pain syndrome. Guidelines on the management of urinary and male genital tract infections. Arnhem, The Netherlands: European Association of Urology (EAU). Mar 2008;79-88. [Full Text].

  5. [Guideline] Fall M, Baranowski AP, Elneil S, Engeler D, Hughes J, Messelink EJ, et al. General treatment of chronic pelvic pain. Guidelines on chronic pelvic pain. Arnhem, The Netherlands: European Association of Urology (EAU). Mar 2008;84-97. [Full Text].

  6. Centers for Disease Control and Prevention. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep. Apr 13 2007;56(14):332-6. [Medline][Full Text].

  7. Awadh B, Watson K, Abdou NI. Wegener prostatitis presenting with acute urinary retention. J Clin Rheumatol. Feb 2006;12(1):50-1. [Medline].

  8. Beckman TJ, Edson RS. Methicillin-resistant Staphylococcus aureus prostatitis. Urology. Apr 2007;69(4):779.e1-3. [Medline].

  9. Berger RE, Krieger JN, Rothman I, Muller CH, Hillier SL. Bacteria in the prostate tissue of men with idiopathic prostatic inflammation. J Urol. Mar 1997;157(3):863-5. [Medline].

  10. Berghuis JP, Heiman JR, Rothman I, Berger RE. Psychological and physical factors involved in chronic idiopathic prostatitis. J Psychosom Res. Oct 1996;41(4):313-25. [Medline].

  11. Collins MM, Stafford RS, O'Leary MP, Barry MJ. How common is prostatitis? A national survey of physician visits. J Urol. Apr 1998;159(4):1224-8. [Medline].

  12. Criste G, Gray D, Gallo B. Prostatitis: a review of diagnosis and management. Nurse Pract. Jul 1994;19(7):32-3, 37-8. [Medline].

  13. de la Rosette JJ, Giesen RJ, Huynen AL, Aarnink RG, van Iersel MP, Debruyne FM, et al. Automated analysis and interpretation of transrectal ultrasonography images in patients with prostatitis. Eur Urol. 1995;27(1):47-53. [Medline].

  14. Donovan DA, Nicholas PK. Prostatitis: diagnosis and treatment in primary care. Nurse Pract. Apr 1997;22(4):144-6, 149-56. [Medline].

  15. Elert A, von Knobloch R, Nusser R, Heidenreich A, Hofmann R. Isolated candidal prostatitis. J Urol. Jan 2000;163(1):244. [Medline].

  16. Feneley M, Kirby RS, Parkinson C. Clinico-pathological findings simulating prostatic malignancy following sclerotherapy: a diagnostic pitfall. Br J Urol. Jan 1996;77(1):157-8. [Medline].

  17. Gebo KA. Prostatic tuberculosis in an HIV infected male. Sex Transm Infect. Apr 2002;78(2):147-8. [Medline].

  18. Habermacher GM, Chason JT, Schaeffer AJ. Prostatitis/chronic pelvic pain syndrome. Annu Rev Med. 2006;57:195-206. [Medline].

  19. Huong DL, Papo T, Piette JC, Wechsler B, Bletry O, Richard F, et al. Urogenital manifestations of Wegener granulomatosis. Medicine (Baltimore). May 1995;74(3):152-61. [Medline].

  20. Krieger JN, Egan KJ, Ross SO, Jacobs R, Berger RE. Chronic pelvic pains represent the most prominent urogenital symptoms of "chronic prostatitis". Urology. Nov 1996;48(5):715-21; discussion 721-2. [Medline].

  21. Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999;282:236-7. [Medline].

  22. Luzzi G. The prostatitis syndromes. Int J STD AIDS. Nov-Dec 1996;7(7):471-8. [Medline].

  23. Mastroianni A, Coronado O, Manfredi R, Chiodo F, Scarani P. Acute cytomegalovirus prostatitis in AIDS. Genitourin Med. Dec 1996;72(6):447-8. [Medline].

  24. McNaughton Collins M, MacDonald R, Wilt TJ. Diagnosis and treatment of chronic abacterial prostatitis: a systematic review. Ann Intern Med. Sep 5 2000;133(5):367-81. [Medline][Full Text].

  25. Mehik A, Hellström P, Sarpola A, Lukkarinen O, Järvelin MR. Fears, sexual disturbances and personality features in men with prostatitis: a population-based cross-sectional study in Finland. BJU Int. Jul 2001;88(1):35-8. [Medline].

  26. Middleton G, Karp D, Lee E, Cush J. Wegener's granulomatosis presenting as lower back pain with prostatitis and ureteral obstruction. J Rheumatol. Mar 1994;21(3):566-9. [Medline].

  27. Nargund VH, Stewart PA. Acute bacterial prostatitis with osteomyelitis. J R Soc Med. Jun 1995;88(6):355P-356P. [Medline].

  28. Nickel JC. alpha-Blockers for Treatment of the Prostatitis Syndromes. Rev Urol. 2005;7 Suppl 8:S18-25. [Medline][Full Text].

  29. Nickel JC, Downey J, Hunter D, Clark J. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol. Mar 2001;165(3):842-5. [Medline].

  30. Nickel JC, Siemens DR, Lundie MJ. Re: Ameliorative effect of allopurinol on nonbacterial prostatitis: a parallel double-blind controlled study. J Urol. Feb 1997;157(2):628-9. [Medline].

  31. Parks RW, Henry PG, Abram WP, Best BG. Primary non-Hodgkin's lymphoma of the prostate mimicking acute prostatitis. Br J Urol. Sep 1995;76(3):409. [Medline].

  32. Persson BE, Ronquist G. Evidence for a mechanistic association between nonbacterial prostatitis and levels of urate and creatinine in expressed prostatic secretion. J Urol. Mar 1996;155(3):958-60. [Medline].

  33. Riegel P, Ruimy R, de Briel D, Prévost G, Jehl F, Bimet F, et al. Corynebacterium seminale sp. nov., a new species associated with genital infections in male patients. J Clin Microbiol. Sep 1995;33(9):2244-9. [Medline].

  34. Schaeffer AJ. Clinical practice. Chronic prostatitis and the chronic pelvic pain syndrome. N Engl J Med. Oct 19 2006;355(16):1690-8. [Medline].

  35. Sindhwani P, Wilson CM. Prostatitis and serum prostate-specific antigen. Curr Urol Rep. Jul 2005;6(4):307-12. [Medline].

  36. Veneziano S, Pavlica P, Mannini D. Color Doppler ultrasonographic scanning in prostatitis: clinical correlation. Eur Urol. 1995;28(1):6-9. [Medline].

  37. Wagenlehner FM, Naber KG. Prostatitis: the role of antibiotic treatment. World J Urol. 2003;21(2):105-8. [Medline].

  38. Wise GJ, Shteynshlyuger A. How to diagnose and treat fungal infections in chronic prostatitis. Curr Urol Rep. 2006;7(4):320-8. [Medline].

Further Reading

Keywords

prostatitis, acute bacterial prostatitis, chronic bacterial prostatitis, nonbacterial prostatitis, prostatodynia, prostate gland, bacterial prostatitis, chronic pelvic pain syndrome, CPPS, asymptomatic inflammatory prostatitis, prostatic inflammation

Contributor Information and Disclosures

Author

Tarlan Hedayati, MD, Instructor of Clinical Emergency Medicine, Director of Observation Unit, Director of Chest Pain Unit, Department of Emergency Medicine, Los Angeles County/University of Southern California Medical Center
Tarlan Hedayati, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Molly Keegan, MD, Resident Physician, Department of Emergency Medicine, Los Angeles County and USC Medical Center
Disclosure: Nothing to disclose.

Medical Editor

David S Howes, MD, Residency Program Director, Professor of Medicine, Section of Emergency Medicine, University of Chicago/Pritzker School of Medicine
David S Howes, MD is a member of the following medical societies: American College of Emergency Physicians, American College of Physicians-American Society of Internal Medicine, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Eddy Lang, MDCM, CCFP (EM), CSPQ, Assistant Professor, Department of Family Medicine, McGill University; Consulting Staff, Department of Emergency Medicine, The Sir Mortimer B Davis-Jewish General Hospital
Eddy Lang, MDCM, CCFP (EM), CSPQ is a member of the following medical societies: American College of Emergency Physicians
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Robert E O'Connor, MD, MPH, Professor and Chair, Department of Emergency Medicine, University of Virginia Health System
Robert E O'Connor, MD, MPH is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American College of Physician Executives, American Heart Association, American Medical Association, Medical Society of Delaware, National Association of EMS Physicians, Society for Academic Emergency Medicine, and Wilderness Medical Society
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.